Jump to main content
Jump to site search

Issue 23, 2018
Previous Article Next Article

Silicon nanowire-based multifunctional platform for chemo-photothermal synergistic cancer therapy

Author affiliations

Abstract

Combination therapies for cancer have been promising strategies to reverse multidrug resistance, improve treatment efficiency, and minimize side effects. Herein, a new type of multifunctional silicon nanowire (MFSiNW)-based system, i.e., iron oxide nanoparticle and gold nanoparticle decorated silicon nanowires (IONPs@AuNPs@SiNWs), is prepared through a facile synthetic strategy. The resultant nanohybrids could load therapeutic drug molecules (e.g., doxorubicin, DOX) with high drug loading capacity (2000 mg gāˆ’1), and be simultaneously responsive to pH/NIR (near-infrared) light/magnetism, thus enabling high-efficacy synergistic treatment of drug-resistant cancer cells. The current work provides the pioneering demonstration of silicon nanomaterial-based combinational cancer treatment with high therapeutic efficiency.

Graphical abstract: Silicon nanowire-based multifunctional platform for chemo-photothermal synergistic cancer therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 08 Nov 2017, accepted on 10 Apr 2018 and first published on 11 Apr 2018


Article type: Paper
DOI: 10.1039/C7TB02907A
Citation: J. Mater. Chem. B, 2018,6, 3876-3883
  •   Request permissions

    Silicon nanowire-based multifunctional platform for chemo-photothermal synergistic cancer therapy

    D. Guo, X. Ji, H. Wang, Bin Sun, B. Chu, Y. Shi, Y. Su and Y. He, J. Mater. Chem. B, 2018, 6, 3876
    DOI: 10.1039/C7TB02907A

Search articles by author

Spotlight

Advertisements